Index of reports
> Cases with Renal Impairment ()
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cyclophosphamide where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of Next >>
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23
Patient: male
Reactions: Phlebitis, Lymphocyte Percentage Decreased, Hydronephrosis, Arterial Thrombosis Limb, Urinary Tract Infection, Cystitis Noninfective, Human Polyomavirus Infection, Prothrombin Time Prolonged, Urethritis, Blood Fibrinogen Increased, Genitourinary Tract Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 500 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, first 3 days of each cycle (6 cycles)
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Campath
Dosage: 30 mg/m2, first 3 days of each cycle (6 cycles)
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Bactrim; Valganciclovir; Vfend; Folic Acid
Possible Cyclophosphamide side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-08-21
Patient: 75 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Renal Impairment
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Revlimid
Administration route: Oral
End date: 2012-06-26
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
End date: 2012-06-26
Cyclophosphamide
Dosage: 500 milligram
Administration route: Oral
End date: 2012-06-26
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Cyclophosphamide
Dosage: 500 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-17
Patient: male
Reactions: Hydronephrosis, Urinary Tract Infection, Cystitis Noninfective, Urethritis, Human Polyomavirus Infection, Renal Impairment, Adenovirus Infection, Prostatomegaly, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Campath
Dosage: 30 mg/m2, unk
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Cyclophosphamide
Dosage: 500 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Fludara
Dosage: 80 mg/m2, unk
Administration route: Oral
Indication: Chronic Lymphocytic Leukaemia
Start date: 2008-07-15
End date: 2008-12-03
Other drugs received by patient: Bactrim; Vfend; Valganciclovir; Folic Acid
Possible Cyclophosphamide side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-31
Patient: 75 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Renal Impairment
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
End date: 2012-06-26
Cyclophosphamide
Dosage: 500 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
End date: 2012-06-26
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Cyclophosphamide
Dosage: 500 milligram
Administration route: Oral
End date: 2012-06-26
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Possible Cyclophosphamide side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-30
Patient: 70 year old female
Reactions: Renal Impairment, Hyperkalaemia, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Dexamethasone
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Revlimid
Dosage: 10 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Possible Cyclophosphamide side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-23
Patient: 54 year old female
Reactions: Renal Impairment, Respiratory Failure, Interstitial Lung Disease, Immunosuppressant Drug Level Increased, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Methylprednisolone
Indication: Interstitial Lung Disease
Prednisolone
Dosage: 1 mg/kg, per day
Indication: Interstitial Lung Disease
Cyclophosphamide
Indication: Interstitial Lung Disease
Cyclosporine
Dosage: 0.17 mg/kg, per hour
Indication: Interstitial Lung Disease
Other drugs received by patient: Immune Globulin NOS
Possible Cyclophosphamide side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 54 year old female
Reactions: Renal Impairment, Interstitial Lung Disease, Respiratory Failure, Immunosuppressant Drug Level Increased, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 1 mg/kg, per day
Indication: Interstitial Lung Disease
Cyclosporine
Dosage: 0.17 mg/kg, per hour
Indication: Interstitial Lung Disease
Methylprednisolone
Indication: Interstitial Lung Disease
Cyclophosphamide
Indication: Interstitial Lung Disease
Other drugs received by patient: Immune Globulin NOS
Possible Cyclophosphamide side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-20
Patient: 54 year old female
Reactions: Renal Impairment, Interstitial Lung Disease, Respiratory Failure, Immunosuppressant Drug Level Increased, Disease Progression
Adverse event resulted in: death
Drug(s) suspected as cause:
Prednisolone
Dosage: 1 mg/kg, per day
Indication: Interstitial Lung Disease
Cyclosporine
Dosage: 0.17 mg/kg, per hour
Indication: Interstitial Lung Disease
Methylprednisolone
Indication: Interstitial Lung Disease
Cyclophosphamide
Indication: Interstitial Lung Disease
Other drugs received by patient: Immune Globulin NOS
Possible Cyclophosphamide side effects in 75 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-07-12
Patient: 75 year old male
Reactions: Pneumocystis Jiroveci Pneumonia, Renal Impairment
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Revlimid
Dosage: 25 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Cyclophosphamide
Dosage: 500 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Dexamethasone
Dosage: 20 milligram
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2012-04-13
Revlimid
Administration route: Oral
Possible Cyclophosphamide side effects in 67 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-02
Patient: 67 year old male
Reactions: Weight Decreased, Anaemia, Acute Phosphate Nephropathy, Mental Status Changes, Hypercalcaemia, Hyperuricaemia, Haemodialysis, Tumour Lysis Syndrome, Renal Impairment, Oliguria, Leukocytosis, Thrombocytopenia, Decreased Appetite, Renal Failure Acute, Hepatosplenomegaly
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Indication: Chemotherapy
Vincristine
Indication: Chemotherapy
Dexamethasone Sodium Phosphate
Indication: Chemotherapy
Cyclophosphamide
Indication: Chemotherapy
Possible Cyclophosphamide side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-06-11
Patient: 43 year old male
Reactions: Liver Injury, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Device Related Infection, Death, Renal Failure, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Cardiac Failure, Respiratory Failure, Hallucination, Visual, Neutropenia, Mycobacterium Fortuitum Infection, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Oseltamivir
Dosage: 75 mg, 2x/day
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Amphotericin B
Indication: Aspergillosis
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Ciprofloxacin HCL
Dosage: 60 mg
Voriconazole
Dosage: unk
Indication: Aspergillosis
Teicoplanin
Dosage: 400 mg, 1x/day
Indication: Product Used FOR Unknown Indication
Meropenem
Dosage: 1 g, 2x/day
Indication: Product Used FOR Unknown Indication
Possible Cyclophosphamide side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-30
Patient: 43 year old male
Reactions: Liver Injury, Device Related Infection, Death, Cardio-Respiratory Arrest, Mycobacterium Fortuitum Infection, Bronchopulmonary Aspergillosis, Dyspnoea, Haemoptysis, Sepsis Syndrome, Renal Failure, Renal Impairment, Cardiac Failure, Hallucination, Visual, Respiratory Failure, Neutropenia, Influenza
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Ciprofloxacin HCL
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Prednisolone
Dosage: 60 mg, unk
Indication: Immunosuppression
Oseltamivir
Indication: Product Used FOR Unknown Indication
Teicoplanin
Dosage: unk
Indication: Product Used FOR Unknown Indication
Cyclophosphamide
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Immunosuppression
Clarithromycin
Dosage: 500 mg, 2x/day
Indication: Mycobacterium Fortuitum Infection
Voriconazole
Dosage: unk
Indication: Aspergillosis
Meropenem
Indication: Product Used FOR Unknown Indication
Amphotericin B
Indication: Aspergillosis
Possible Cyclophosphamide side effects in male
Reported by a physician from France on 2012-05-23
Patient: male, weighing 68.0 kg (149.6 pounds)
Reactions: Complications of Transplanted Kidney, Wound Dehiscence, Malnutrition, Bronchial Obstruction, Anastomotic Haemorrhage, Renal Impairment, Unevaluable Event, Culture Wound Positive, Thrombocytopenia, Escherichia Sepsis
Adverse event resulted in: death, life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Esomeprazole Magnesium
Start date: 2011-01-16
End date: 2011-02-01
Prednisone TAB
Administration route: Oral
Indication: Transplant Rejection
Cyclosporine
Everolimus
Indication: Product Used FOR Unknown Indication
Start date: 2011-02-02
End date: 2011-02-09
Cellcept
Dosage: permanently discontinued. date of last dose prior to sae: 08 march 2011.
Administration route: Oral
Start date: 2011-03-01
End date: 2011-03-08
Cellcept
Dosage: frequency: everyday. temporarily interrupted
Administration route: Oral
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-02-09
Prednisone TAB
Dosage: date of last dose prior to sae: 16 march 2011.
Administration route: Oral
Cyclophosphamide
Administration route: Oral
Indication: Transplant Rejection
Start date: 2011-01-17
End date: 2011-02-01
Methylprednisolone and Methylprednisolone
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-01-15
Basiliximab
Indication: Transplant Rejection
Start date: 2011-01-15
End date: 2011-01-15
Valcyte
Dosage: twice a week
Start date: 2011-01-29
End date: 2011-02-01
Cyclosporine
Sulfamethoxazole and Trimethoprim
Start date: 2011-01-24
End date: 2011-02-01
Ranitidine HCL
Start date: 2011-02-02
End date: 2011-02-09
Other drugs received by patient: Adancor; Amlodipine Besylate; Insulatard NPH Human; Econazole Nitrate; Potassium Chloride; Adancor; Imodium; Alfuzosin HCL; Calcidia; Aspirin; Mirtazapine; Calcidia; Lasix; Eprex; Nitroderm; Potassium Chloride; Amoxicillin; Lasix; Sodium Bicarbonate; Aluminum Hydroxide and Magnesium Trisilicate
Possible Cyclophosphamide side effects in 43 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-15
Patient: 43 year old male
Reactions: Right Ventricular Failure, Liver Injury, Dyspnoea, Haemoptysis, Cholestasis, H1n1 Influenza, Acid Fast Bacilli Infection, Sepsis Syndrome, Renal Impairment, Cardio-Respiratory Arrest, Respiratory Failure, Hallucination, Visual, Aspergillosis, Neutropenia, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Prednisolone
Dosage: 60 mg, qd
Administration route: Oral
Indication: Vasculitis
Cyclophosphamide
Dosage: 100 mg, qd
Administration route: Oral
Indication: Vasculitis
Other drugs received by patient: Ciprofloxacin; Ciprofloxacin; Clarithromycin; Clarithromycin
Possible Cyclophosphamide side effects in 70 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-05-10
Patient: 70 year old female
Reactions: Renal Impairment, Hyperkalaemia, Anaemia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Revlimid
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Dexamethasone
Indication: Multiple Myeloma
Start date: 2010-09-24
End date: 2010-11-03
Possible Cyclophosphamide side effects in
Reported by a physician from Greece on 2012-05-08
Patient:
Reactions: Sudden Death, Orthostatic Hypotension, Constipation, Myalgia, Neuropathy Peripheral, Fatigue, Oedema Peripheral, Hypocalcaemia, Acute Myocardial Infarction, Blood Creatinine Increased, Thrombocytopenia, Hypotension, Hyponatraemia, Rash, Cerebrovascular Accident, Renal Impairment, Diarrhoea, Amyloidosis, Neutropenia, Deep Vein Thrombosis, Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Revlimid
Dosage: 15 milligram
Administration route: Oral
Dexamethasone
Dosage: 20 milligram
Indication: Amyloidosis
Cyclophosphamide
Dosage: level 0: 50mg, level 1-4: 100mg
Indication: Amyloidosis
Revlimid
Dosage: level 0-1: 10mg, level 2: 15mg, level 3: 20mg, level 4: 25mg
Administration route: Oral
Indication: Amyloidosis
Revlimid
Dosage: 15 milligram
Administration route: Oral
Other drugs received by patient: Aspirin
Possible Cyclophosphamide side effects in 41 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-04
Patient: 41 year old male, weighing 77.0 kg (169.4 pounds)
Reactions: Jaundice, Confusional State, Somnolence, Treatment Noncompliance, Overdose, Left Ventricular Dysfunction, Cholangitis, Acute Respiratory Distress Syndrome, Bone Marrow Failure, Thrombocytopenia, Engraftment Syndrome, Neurological Decompensation, Pseudomonas Infection, Haemoglobin Decreased, Mucosal Inflammation, Cholelithiasis, Renal Failure, Renal Impairment, Ventricular Dysfunction, Miosis, Enterococcus Test Positive, Multi-Organ Disorder, Septic Shock, Staphylococcus Test Positive
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Busulfex
Dosage: 3.2 mg/kg, qd, intravenous, 232.9 mg milligram(s), intravenous
Indication: Myeloid Leukaemia
Start date: 2011-08-19
Busulfex
Dosage: 3.2 mg/kg, qd, intravenous, 232.9 mg milligram(s), intravenous
Indication: Myeloid Leukaemia
Start date: 2011-08-16
Cyclophosphamide
Dosage: 60 mg/kg, qd, intravenous
Indication: Acute Myeloid Leukaemia
Start date: 2011-08-21
End date: 2011-08-22
Possible Cyclophosphamide side effects in
Reported by a health professional (non-physician/pharmacist) from China on 2012-03-26
Patient:
Reactions: Pancreatitis Acute, Gastrointestinal Haemorrhage, Tuberculosis, Lung Infection, Fungal Sepsis, Renal Impairment, Fungal Infection, Central Nervous System Infection, Meningitis Cryptococcal, Bone Marrow Failure, Skin Infection, Candidiasis, Pneumococcal Sepsis
Drug(s) suspected as cause:
Cytarabine
Indication: Lymphoma
Ifosfamide
Indication: Lymphoma
Methotrexate
Indication: Lymphoma
Leucovorin Calcium
Indication: Lymphoma
Etoposide
Indication: Lymphoma
Pirarubicin
Indication: Lymphoma
Prednisone
Indication: Lymphoma
Dexamethasone
Indication: Lymphoma
Rituximab
Indication: Lymphoma
Vincristine
Indication: Lymphoma
Cyclophosphamide
Mesna
Indication: Lymphoma
Doxorubicin HCL
Indication: Lymphoma
Mitoxantrone
Indication: Lymphoma
Other drugs received by patient: Stavudine; Zidovudine; Lamivudine (Epivir Hbv); Nevirapine
Possible Cyclophosphamide side effects in female
Reported by a individual with unspecified qualification from United States on 2012-03-01
Patient: female, weighing 19.7 kg (43.3 pounds)
Reactions: Blood Pressure Increased, Pancreatitis Acute, Renal Impairment, Continuous Haemodiafiltration
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1690 mg
End date: 2011-12-30
Mercaptopurine
Dosage: 1500 mg
End date: 2012-01-11
Methotrexate
Dosage: 48 mg
End date: 2011-12-22
PEG-L-Asparaginase (K-H)
Dosage: 4075 unit
End date: 2012-01-12
Vincristine Sulfate
Dosage: 5.1 mg
End date: 2012-01-19
Cytarabine
Dosage: 1040 mg
End date: 2012-01-08
Possible Cyclophosphamide side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-01-26
Patient: 8 year old female
Reactions: Pulmonary Hypertension, Hepatic Function Abnormal, Pulmonary Veno-Occlusive Disease, Toxicity To Various Agents, Idiopathic Pneumonia Syndrome, Haemodialysis, Pulmonary Haemorrhage, Mucosal Inflammation, Renal Impairment, Malaise, Respiratory Failure, Adenovirus Infection, Cytomegalovirus Infection, Bacterial Sepsis, Methylobacterium Infection, Pneumonitis
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Methotrexate
Indication: Prophylaxis Against Graft Versus Host Disease
Cyclosporine
Indication: Prophylaxis Against Graft Versus Host Disease
Busulfan
Dosage: tablet 14 mg/kg
Indication: Bone Marrow Conditioning Regimen
Cyclophosphamide
Dosage: 200 mg/kg
Indication: Bone Marrow Conditioning Regimen
Alemtuzumab
Dosage: 0.3 mg/kg
Indication: Bone Marrow Conditioning Regimen
Possible Cyclophosphamide side effects in 46 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-01-03
Patient: 46 year old male, weighing 106.0 kg (233.2 pounds)
Reactions: Metastatic Malignant Melanoma, Alanine Aminotransferase Increased, Chromaturia, Pyrexia, Renal Impairment, Neoplasm Malignant, Aspartate Aminotransferase Increased, Liver Function Test Abnormal, Dizziness, Rash Maculo-Papular
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vemurafenib
Start date: 2011-12-06
End date: 2011-12-13
Cyclophosphamide
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-31
Proleukin
Indication: Metastatic Malignant Melanoma
Start date: 2011-11-02
End date: 2011-11-16
Ipilimumab
Dosage: also on 11mar2011 and 22nov2011.
Indication: Metastatic Malignant Melanoma
Start date: 2011-10-04
Possible Cyclophosphamide side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-12-29
Patient: 8 year old female, weighing 22.0 kg (48.4 pounds)
Reactions: Pulmonary Hypertension, Idiopathic Pneumonia Syndrome, Liver Disorder, Mucosal Inflammation, Pulmonary Haemorrhage, Renal Impairment, Venoocclusive Disease, Respiratory Failure, Cytomegalovirus Infection, Bacterial Sepsis
Adverse event resulted in: death
Drug(s) suspected as cause:
Busulfan
Administration route: Oral
Indication: Bone Marrow Failure
Start date: 2011-04-25
End date: 2011-04-28
Mabcampath
Indication: Bone Marrow Transplant
Start date: 2011-04-26
End date: 2011-04-28
Methotrexate
Indication: Graft Versus Host Disease
Start date: 2011-05-08
End date: 2011-05-11
Cyclophosphamide
Indication: Bone Marrow Failure
Start date: 2011-04-29
End date: 2011-05-02
Other drugs received by patient: Immune Globulin NOS; Thiotepa; Allopurinol; Dapsone; Linezolid; Amphotericin B; Defibrotide; Leucovorin Calcium; Acetaminophen; Caspofungin Acetate; Hydrocortisone; Phenytoin; Mesna; Cyclosporine; Isoniazid; Octreotide Acetate; Metronidazole; Meperidine HCL
Possible Cyclophosphamide side effects in female
Reported by a individual with unspecified qualification from Japan on 2011-12-13
Patient: female, weighing 56.0 kg (123.2 pounds)
Reactions: Hepatic Function Abnormal, Disseminated Intravascular Coagulation, Norovirus Test Positive, Renal Impairment, Lung Disorder, Diarrhoea, Platelet Count Decreased, Circulatory Collapse, Infusion Related Reaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Taxotere
Indication: Breast Cancer Metastatic
Start date: 2009-04-27
End date: 2009-07-10
Cyclophosphamide
Indication: Breast Cancer Metastatic
Start date: 2009-04-27
End date: 2009-07-10
Herceptin
Indication: Breast Cancer Metastatic
Start date: 2009-07-31
End date: 2009-07-31
Herceptin
Start date: 2009-08-21
End date: 2009-08-21
Possible Cyclophosphamide side effects in 50 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-12-01
Patient: 50 year old female
Reactions: Metastases To Liver, Bile Duct Cancer, Metastases To Stomach, Colonic Polyp, Neuropathy Peripheral, Pleural Effusion, Cardiotoxicity, Thrombocytopenia, Blood Creatinine Increased, Metastases To Lung, Hepatic Cirrhosis, Cardiac Failure Congestive, Bone Marrow Transplant, Blood Urea Increased, Acute Lymphocytic Leukaemia Recurrent, Congestive Cardiomyopathy, Renal Cyst, Toxicity To Various Agents, Rash, Osteosclerosis, Renal Impairment, Diarrhoea, Renal Mass
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine Sulfate
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Elspar
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Etoposide
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Prednisone TAB
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Cyclophosphamide
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Cytarabine
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Methotrexate
Dosage: not reported, intrathecal
Indication: Acute Lymphocytic Leukaemia
Mitoxantrone Hydrochloride
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
(Therapeutic Radiopharmaceuticals)
Dosage: not reported
Indication: Acute Lymphocytic Leukaemia
Possible Cyclophosphamide side effects in 16 year old female
Reported by a physician from Algeria on 2011-11-11
Patient: 16 year old female, weighing 34.0 kg (74.8 pounds)
Reactions: Off Label Use, Renal Impairment, Drug Ineffective, Systemic Lupus Erythematosus, NO Therapeutic Response
Drug(s) suspected as cause:
Neoral
Indication: Systemic Lupus Erythematosus
Mabthera
Indication: Systemic Lupus Erythematosus
Mycophenolate Mofetil (Cellcept)
Indication: Systemic Lupus Erythematosus
Cyclophosphamide
Indication: Systemic Lupus Erythematosus
Possible Cyclophosphamide side effects in male
Reported by a health professional (non-physician/pharmacist) from Canada on 2011-11-02
Patient: male
Reactions: Thyroid Cancer, Neuroblastoma, Maternal Exposure During Pregnancy, Respiratory Depression, Renal Impairment, Developmental Delay, Vena Cava Injury, Iron Deficiency Anaemia, Cryptorchism, Nervous System Disorder, Oesophageal Atresia, Carpus Curvus
Drug(s) suspected as cause:
Mercaptopurine
Indication: Maternal Exposure During Pregnancy
Prednisone
Indication: Maternal Exposure During Pregnancy
Vincristine
Indication: Maternal Exposure During Pregnancy
Aminopterin
Indication: Maternal Exposure During Pregnancy
Cyclophosphamide
Indication: Maternal Exposure During Pregnancy
Possible Cyclophosphamide side effects in 16 year old female
Reported by a physician from Algeria on 2011-10-31
Patient: 16 year old female, weighing 34.0 kg (74.8 pounds)
Reactions: Off Label Use, Renal Impairment, Drug Ineffective, Systemic Lupus Erythematosus
Drug(s) suspected as cause:
Mycophenolate Mofetil (Cellcept)
Indication: Systemic Lupus Erythematosus
Neoral
Indication: Systemic Lupus Erythematosus
Cyclophosphamide
Indication: Systemic Lupus Erythematosus
Mabthera
Indication: Systemic Lupus Erythematosus
Possible Cyclophosphamide side effects in 67 year old female
Reported by a physician from United States on 2011-10-31
Patient: 67 year old female
Reactions: Renal Impairment, Drug Ineffective, Hyperglycaemia, Alveolar Proteinosis, Myopathy
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Indication: Wegener's Granulomatosis
Prednisone
Indication: Wegener's Granulomatosis
Mycophenolate Mofetil
Dosage: 1.5 g
Cyclophosphamide
Indication: Interstitial Lung Disease
Sildenafil
Indication: Pulmonary Hypertension
Mycophenolate Mofetil
Dosage: 500 mg
Indication: Wegener's Granulomatosis
Mycophenolate Mofetil
Dosage: 2000 mg
Indication: Interstitial Lung Disease
Prednisone
Indication: Interstitial Lung Disease
Possible Cyclophosphamide side effects in 67 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2011-10-24
Patient: 67 year old female
Reactions: Clubbing, Superinfection, Blood Lactate Dehydrogenase Increased, Hyperglycaemia, Pyrexia, Alveolar Proteinosis, Myopathy, Renal Impairment, Dyspnoea Exertional, Oedema Peripheral, Hypoxia, Cough
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mycophenolate Mofetil
Dosage: 500 mg; qd; 2000 mg;qd; 1500 mg; qd
Indication: Wegener's Granulomatosis
Prednisone
Indication: Wegener's Granulomatosis
Cyclophosphamide
Indication: Wegener's Granulomatosis
Other drugs received by patient: Sildenafil
Possible Cyclophosphamide side effects in 8 year old female
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2011-10-21
Patient: 8 year old female, weighing 22.0 kg (48.4 pounds)
Reactions: Pulmonary Hypertension, Idiopathic Pneumonia Syndrome, Liver Disorder, Mucosal Inflammation, Pulmonary Haemorrhage, Renal Impairment, Venoocclusive Disease, Respiratory Failure, Bacterial Sepsis, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Busulfan
Administration route: Oral
Indication: Bone Marrow Failure
Start date: 2011-04-25
End date: 2011-04-28
Cyclophosphamide
Indication: Bone Marrow Failure
Start date: 2011-04-29
End date: 2011-05-02
Methotrexate
Indication: Graft Versus Host Disease
Start date: 2011-05-08
End date: 2011-05-11
Mabcampath
Indication: Bone Marrow Transplant
Start date: 2011-04-26
End date: 2011-04-28
Other drugs received by patient: Metronidazole; Acetaminophen; Thiotepa; Mesna; Allopurinol; Cyclosporine; Dapsone; Ganciclovir; Immune Globulin NOS; Meperidine HCL; Caspofungin Acetate; Defibrotide; Hydrocortisone; Octreotide Acetate; Phenytoin; Leucovorin Calcium; Isoniazid; Amphotericin B; Linezolid
Page 1 Next >>
|